Free Trial

Global Cord Blood (CO) Stock Price, News & Analysis

+0.02 (+1.63%)
(As of 05/20/2024 ET)
Today's Range
50-Day Range
52-Week Range
3,536 shs
Average Volume
216,519 shs
Market Capitalization
$151.94 million
P/E Ratio
Dividend Yield
Price Target
CO stock logo

About Global Cord Blood Stock (NYSE:CO)

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

CO Stock Price History

CO Stock News Headlines

Global Cord Blood Corporation (CORBF)
See More Headlines
Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Miscellaneous health & allied services, not elsewhere classified
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$0.30 per share
Book Value
$6.34 per share


Free Float
Market Cap
$151.94 million
No Data
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ting Zheng
    Chairman & Chief Executive Officer
  • Bing Chuen Chen
    Chief Financial Officer & Director
  • Xin Xu
    Chief Technology Officer
  • Rui Arashiyama
    CEO-Guangdong & Zhejiang Divisions

CO Stock Analysis - Frequently Asked Questions

How have CO shares performed in 2024?

Global Cord Blood's stock was trading at $1.22 at the start of the year. Since then, CO stock has increased by 2.5% and is now trading at $1.25.
View the best growth stocks for 2024 here

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) released its quarterly earnings results on Tuesday, June, 26th. The medical research company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter.

Is Global Cord Blood a good dividend stock?

Global Cord Blood (NYSE:CO) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CO.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CO) was last updated on 5/22/2024 by Staff

From Our Partners